| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/17/2010 | WO2010030342A3 Heparosan polymers and methods of making and using same for the enhancement of therapeutics |
| 06/17/2010 | WO2010029575A3 Lyophilized docetaxel containing formulation |
| 06/17/2010 | WO2010025176A3 Mcp-1 delivery system |
| 06/17/2010 | WO2010024576A3 Sustained release tablet containing talniflumate with enhanced body absorption |
| 06/17/2010 | WO2010022051A3 Disruptors of early/recycling endosomes |
| 06/17/2010 | WO2009053339A3 Cholesterol derivatives of inhibitors of viral fusion |
| 06/17/2010 | US20100152649 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 06/17/2010 | US20100152414 Multi-arm polymer prodrugs |
| 06/17/2010 | US20100152410 High molecular weight polymers, devices and method for making and using same |
| 06/17/2010 | US20100152149 Formulation |
| 06/17/2010 | US20100152130 Treatment of cancer with glutamine |
| 06/17/2010 | US20100152111 Polymer-based sustained release device |
| 06/17/2010 | US20100152097 Polymer-based sustained release device |
| 06/17/2010 | US20100152095 Wound healing |
| 06/17/2010 | US20100151047 Effect pigments |
| 06/17/2010 | US20100151038 Granular material for dosage forms |
| 06/17/2010 | US20100151036 Multiphase drug delivery system |
| 06/17/2010 | US20100151029 Anti-infectious hydrogel compositions |
| 06/17/2010 | US20100150981 Sustained release systems of ascorbic acid phosphate |
| 06/17/2010 | US20100150925 Treatment of b-cell cancers with anti-cd70 antibody-drug conjugates |
| 06/17/2010 | US20100150855 Hydroxyl compound and a cosmetic comprising the same |
| 06/17/2010 | US20100150850 Dispersion, gel and emulsification system |
| 06/17/2010 | US20100150832 Biodegradable polyketal polymers and methods for their formation and use |
| 06/17/2010 | DE102007050165B4 Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung Stabilized solution, process for their preparation and their use and medicaments in the form of a stabilized solution |
| 06/17/2010 | CA2746442A1 Methods for enhancing stability of polyorthoesters and their formulations |
| 06/17/2010 | CA2746276A1 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy |
| 06/17/2010 | CA2745980A1 Rifaximin complexes |
| 06/17/2010 | CA2744940A1 Methods and compositions for delivery of medicaments to the lungs |
| 06/17/2010 | CA2744367A1 Combined drug administration |
| 06/16/2010 | EP2196538A1 Conjugates prepared with aggregate-free proteins |
| 06/16/2010 | EP2196523A1 Process for producing highly purified orange roughy oil |
| 06/16/2010 | EP2196484A1 Polyhydroxyalkanoate compositions having controlled degradation rates |
| 06/16/2010 | EP2196477A1 Modified recombinant human endostatin and its application |
| 06/16/2010 | EP2196475A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 06/16/2010 | EP2196221A1 Rapidly disintegrating solid preparation |
| 06/16/2010 | EP2196213A1 Immunogenic LHRH compositions and methods relating thereto |
| 06/16/2010 | EP2196195A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 06/16/2010 | EP2196194A1 Process for producing biological ingesta and biological ingesta obtained thereby |
| 06/16/2010 | EP2196193A1 Hydrogels suitable for use in polyp removal |
| 06/16/2010 | EP2195430A2 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 06/16/2010 | EP2195335A1 Diagnostic agent |
| 06/16/2010 | EP2195039A1 Surgical hydrogel |
| 06/16/2010 | EP2195034A2 Peptide-peptidase inhibitor conjugates and methods of making and using same |
| 06/16/2010 | EP2195032A2 Phase ii detoxification and antioxidant activity |
| 06/16/2010 | EP2195028A2 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| 06/16/2010 | EP2195022A1 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
| 06/16/2010 | EP2195001A1 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| 06/16/2010 | EP2194970A2 Enhancement of the efficacy of therapeutic proteins |
| 06/16/2010 | EP2194965A2 Non-aqueous pharmaceutical compositions |
| 06/16/2010 | EP1492526B1 Conjugated prodrugs of cc-1065 analogs |
| 06/16/2010 | EP1370291B1 Device and method for the photodynamic diagnosis of tumor tissue |
| 06/16/2010 | EP1307233B1 Therapeutic polyanhydride compounds for drug delivery |
| 06/16/2010 | CN1994389B Production method of soft capsule for treating pelvic inflammation |
| 06/16/2010 | CN1994296B Pharmaceutical composition containing simvastatin |
| 06/16/2010 | CN1946426B Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof |
| 06/16/2010 | CN1913912B Pharmaceutical compositions and methods for insulin treatment |
| 06/16/2010 | CN1867341B Compositions for controlling parasites comprising a combination of abamectin and milbemycin |
| 06/16/2010 | CN1863557B In-situ gelling drug delivery system |
| 06/16/2010 | CN1857232B Biodegradable nano magnetic capsule loading medicine and its preparing process |
| 06/16/2010 | CN1822822B Saquinavir mesylate oral dosage form |
| 06/16/2010 | CN1812774B Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same |
| 06/16/2010 | CN1635864B Oligosaccharide aldonic acids and their topical use |
| 06/16/2010 | CN1596103B Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus |
| 06/16/2010 | CN1543338B Chitin microparticles and their medical uses |
| 06/16/2010 | CN1517126B Drug compastion with thrombolysis, anti-inflammatory and cell protective function |
| 06/16/2010 | CN1500095B Polymer conjugates of neublastin and methods of using ssame |
| 06/16/2010 | CN1406249B Enhancing the circulating half-life of antibody-based fusion proteins |
| 06/16/2010 | CN101743256A an anti-cancer cytotoxic monoclonal antibody |
| 06/16/2010 | CN101743255A an anti-cancer cytotoxic monoclonal antibody |
| 06/16/2010 | CN101743252A protease stabilized, pegylated insulin analogues |
| 06/16/2010 | CN101743021A Stabilized suspension |
| 06/16/2010 | CN101736439A Adjustable-shape fiber containing magnetic or metallic nanocrystalline |
| 06/16/2010 | CN101735991A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 06/16/2010 | CN101735544A PVA (polyvinyl alcohol) matrix poly-N-isopropyl acrylamide microgel and preparation method thereof |
| 06/16/2010 | CN101735418A Biodegradable cationic polymer and application thereof |
| 06/16/2010 | CN101735410A Reduction-sensitive amphiphilic block copolymer and micelle thereof |
| 06/16/2010 | CN101732728A Anti-inflammatory drug (polysaccharide conjugate) as well as preparation and application of drug composition thereof |
| 06/16/2010 | CN101732727A Preparation method of polyamide-amine dendrimer/2-methoxy estradiol compound with terminal functional groups |
| 06/16/2010 | CN101732726A Film forming agent for milk cow nipple protection film and preparation method thereof |
| 06/16/2010 | CN101732725A Composition for speeding up disintegration of tablet and application thereof |
| 06/16/2010 | CN101732724A Composite micelle carrying anti-tumor medicine and preparation method thereof |
| 06/16/2010 | CN101732723A Polyethylene glycol-poly(lactic-co-glycolic acid)-polylysine nano-delivery system, preparation method and application thereof |
| 06/16/2010 | CN101732722A Novel lubricant and preparation method |
| 06/16/2010 | CN101732721A Biocompatibility nanoparticle and application thereof as drug conveying carrier |
| 06/16/2010 | CN101732720A Preparation and application of anti-cancer medicament carrier with dual functions of targeting and fluorescence |
| 06/16/2010 | CN101732719A Silica nanometer mesoporous hollow sphere with extremely high drug load and preparation method thereof |
| 06/16/2010 | CN101732707A Mercury-free Japanese encephalitis inactivated vaccine composition and application thereof |
| 06/16/2010 | CN101732699A Cyclopeptide nanotube medicinal composition and application thereof |
| 06/16/2010 | CN101732697A Compound frozen ossotide preparation |
| 06/16/2010 | CN101732665A Externally applied Chinese medicinal spray for pain relieving of cancers and preparation method thereof |
| 06/16/2010 | CN101732492A Adinandra nitida leaf flavone oral tablet and preparation method |
| 06/16/2010 | CN101732452A Cleaning tablet of oral cavity and preparation method thereof |
| 06/16/2010 | CN101732446A Emulsified oil for treating tinea pedis and preparation method thereof |
| 06/16/2010 | CN101732413A Chinese medicinal composition for treating arthromyodynia and preparation method thereof |
| 06/16/2010 | CN101732409A Salvia miltiorrhiza soft capsule and preparation method thereof |
| 06/16/2010 | CN101732349A Venenum bufonis nanometer long-circulating liposome and preparation method thereof |
| 06/16/2010 | CN101732347A Antler freeze-dried tablet and production method thereof |
| 06/16/2010 | CN101732346A Deer antler freeze-dried tablet with flat appearance and production method thereof |
| 06/16/2010 | CN101732345A Cisplatin spinal tumor slow-release implant and preparation method thereof |
| 06/16/2010 | CN101732343A Nano perfluocarbon liposome particles and preparation method thereof |